Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Is it really COPD? Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal Hospital Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal.
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
The patient with shortness of breath. Differential diagnosis Asthma Asthma COPD COPD Pneumonia Pneumonia Heart failure Heart failure PE PE Other Other.
Respiratory Pharmacology Dr Mike Iredale October 2010.
Respiratory Failure and Non-Invasive ventilation Sophie Fletcher Consultant Respiratory Physician.
Chronic Disease Management Respiratory & CKD Liz Borlase Brampton Medical Practice.
COPD “Trying to Expire Not Expire” Dr Esyld Watson HST Emergency Medicine.
Ali …. 65 years old C/O exercise intolerance for 2 years.
3MG TRIAL MAGNESIUM’S ROLE IN THE TREATMENT OF ASTHMA.
Obstructive Airways Disease Asthma and COPD Dr H Ahmad VTS 29/04/2009.
Acute severe asthma.
Clinical Knowledge Summaries CKS Chronic obstructive pulmonary disease (COPD) - management Management of stable COPD in primary care, focusing on drug.
Managing acute exacerbations of COPD in primary care.
Respiratory examination, basic investigations and therapeutics Dr Felix Woodhead Consultant Respiratory Physician.
Asthma Diagnosis Prescribing Acute Management Tracey Bradshaw Respiratory Consultant RIE.
+ Asthma & COPD Finals Teaching 2013 Alison Portes FY1.
COPD Alison Boland StR Respiratory medicine. Aims & Objectives Overview of COPD Recap basic knowledge Update on COPD Know when to use nebulisers and home.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
COPD GUIDELINES Sarah Cowdell. WHY GUIDELINES MATTER Predicted to be the third leading cause of death by 2030 Cause of over 30,000 deaths in the UK yearly.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Perform and therapeutic benefit of Using a Nebuliser / Inhaler correctly Devangna Bhatia.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Obstructive Airways Disease Asthma and COPD. Definitions: Asthma: It's a chronic respiratory condition that causes the airways to constrict become inflamed.
Part 2… COAD in the Emergency Department.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Matt Wong + Sheila Murphy Dec 13 th  AKT MINI EXAM  NICE – COPD GUIDELINES  BTS ASTHMA GUIDELINES  INHALER TECHNIQUE  QOF  SPIROMETRY  CSA.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Respiratory COPD/Asthma.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
OSCE Revision Respiratory Mark Woodhead Honorary Clinical Professor of Respiratory Medicine.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Aaqid Akram MBChB (2013) Clinical Education Fellow
Chronic Obstructive Pulmonary Disease Austin Paul K.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
Percent Change in Age-Adjusted Death Rates, U.S., Proportion of 1965 Rate –59% –64% –35% +163% –7% Coronary.
Severe breathlessness
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
COPD Emergency Department Junior Medical Staff Teaching August 2015.
Asthma ( Part 1 ) Dr.kassim.M.sultan F.R.C.P. Objectives: 1-Define asthma 2-Identify its aggravating factors 3-Describe its clinical features 4-Illustrate.
Respiratory Health Asthma and COPD. Definition of asthma 2 Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation.
Current management of COPD and when to refer?
Chronic Obstructive Pulmonary Disease(COPD)
Asthma ED Junior Teaching.
Acute Exacerbations of COPD
Management of Chronic Airflow Obstruction
Managing acute exacerbations of COPD in primary care.
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
COPD By Alaina Darby.
Asthma/ Wheeze and children
Chronic Obstructive Pulmonary Disease
Presentation transcript:

Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician

Obstructive Lung Disease Reduced rate of airflow Wheeze Big lungs Asthma COPD Bronchiectasis

Delivery methods Nebulisers Inhalers –Aerosol –Dry powder –Proprietary types

Drugs Bronchodilators

β 2 agonists Short-acting –Salbutamol –Terbutaline Long-acting –Salmeterol –Formoterol

Antimuscarinics Short-acting –ipratropium Long-acting –tiotropium

Steroids Beclomethasone (BCZ) Budesonide Fluticasone Small- particle BCZ

Combined agents Seretide (Purple) –=serevent (salmeterol) + flixotide (fluticasone) –Evohaler (MDI) or accuhaler (DPI) Symbicort –Oxis (formoterol) + pulmicort (budesonide) –Turbohaler (DPI) –SMART regime

COPD

Definition Airflow obstruction (FEV 1 /FVC < 0.7) Usually progressive Not fully reversible Doesn’t change markedly over few months Predominantly caused by cigarette smoking Differentiation from asthma

G LOBAL INITIATIVE FOR O BSTRUCTIVE L UNG D ISEASE FEV 1 ≥ 80%- GOLD stage 1 FEV 1 = 50-79%- GOLD stage 2 FEV 1 = 30-49%- GOLD stage 3 FEV 1 < 30%- GOLD stage 4 Stage 1 needs symptoms (asymp not COPD) Relatively poor correlation between FEV 1 & symptoms

B ODY MASS INDEX O BSTRUCTION D YSPNOEA E XERCISE CAPACITY BMI : <21 or not Obstruction: broadly GOLD cutoffs Dyspnoea: MRC score Exercise tolerance: 6 minute walk test Composite score better than GOLD

Treatment of stable disease NICE 2010

Stop smoking! Assess every time Not asking is a dereliction of duty Only intervention that changes natural history of disease “If you think you’re breathless now, just you wait…” It is NEVER too late to stop smoking Do not diagnose asthma if you think they may have COPD

Inhaled treatment SOB/ex limitation: SABA/SAMA prn Exacs/SOB –LAMA (tiotropium) regardless of FEV 1 –Or LABA if FEV 1 > 50% Combined LABA/ICS if FEV 1 < 50% Still exacs/SOB –LAMA & Combined LABA/ICS

(Home) Nebulisers Consider in patients with distressing symptoms despite adequate inhaled Rx Only continue if beneficial Side effects can occur Takes up time Placebo effect common

Systemic treatment Corticosteroids – avoid Theophyllines –Only after inhaled Rx tried, or not tolerated –Particular care in the elderly –Levels increased by macrolide/fluoroquinolone Mucolytics –Consider in patients with chronic productive cough –Continue only if beneficial

Oxygen therapy Role is to delay death from cor pulmonale The breathlessness paradox –SOB often good pO 2 –Low sats, often not breathless LTOT –pO 2 < 7.3 kPa when stable –pO 2 < 8 kPa and nocturnal hypoxaemia, polycythaemia or cor pulmonale –Needs to be used for at least 15/24 hours Short burst use (cylinders) – little role

Acute exacerbation of COPD

Definition Sustained worsening of symptoms from usual state Beyond daily day-day variation Acute in onset Often associated with –↑ SOB, ↑ cough, ↑ sputum volume, ↑ sputum purulence May require change in treatment Occur due to precarious V/Q in bad lungs caused by often minor stimuli

Exclude Pneumothorax SVT Myocardial infarction Pulmonary oedema Lung cancer PE Pneumonia (NOT ‘infective exacerbation’) No role for ‘CURB’ score in IECOPD (it is not pneumonia)

Management ↑ frequency of inhaled treatment (often nebulised) Steroids for all (30 mg od 7-14/7) Antibiotics if sputum purulent O 2 given –With care, and control –ALWAYS Venturi acutely –Adjusted by SaO 2 not patient/relative/nurse distress –Guided later by ABGs –With NIV if needed

Other issues Like ‘breathlessness’, fear ‘comfort’ Keep calm Do not give opiates/benzos Get senior help if necessary Nebulise on air, using nasal specs for sup O 2 NIV - use early 2.5 mg salbutamol 2° better than 5 mg 4° IV aminophyline can be useful

Non-invasive ventilation For ACUTE ventilatory failure Treats ↓ pH Allows ↑ FiO 2 without ↑ pCO 2 Only suitable if conscious and protecting airway ↑EPAP (PEEP) useful in pulm oedema and obesity NOT poor man’s ITU NO ROLE IN ACUTE ASTHMA/pneumonia

Asthma

Principles Variable airflow obstruction Cough and wheeze Nocturnal features Specific (allergic) triggers Non-specific triggers Eosinophils in airways Responds to steroids

Acute severe asthma PEFR 50-33% RR ≥ 25 HR ≥ 110 Unable to complete sentences But SpO 2 >92% Worse = life-threatening (silent chest, cynanosis, low SpO 2 ) Better = moderate asthma

Treatment Steroids O 2 Nebs driven with O 2 ABG if low sats or drowsy –Normal pCO 2 is a sign of bad prognosis Senior review Increase inhaled treatment/start it. Educate. Inhaler technique Consider IV bronchodilators

Stable asthma Steroids –Inhaled best –Systemic if admission on the cards Step 1: SABA only Step 2: SABA & ICS mcg/day Step 3: add LABA (combined) Step 4: ↑ ICS dose (stop LABA if no benefit) Step 5: help! Montelukast etc, aminophylline Steroids – psychosocial issues?